-
Trade Mark Update: August 2017
Innofy’s monthly review of most noteworthy Australian Trade Mark Office (ATMO) decisions handed down in August 2017.
-
Innofy Invited to Present at Ci2017 Asia Pacific
Innofy is honoured to be invited to the Ci2017 Asia Pacific Innovation Conference (Melbourne, Australia). We will showcase our innovative strategies in intellectual property as well as touch upon our AI development projects. Let us know if you will be there!
-
Five Strategies for Obtaining Diagnostic Method Patents in the United States
We have presented five strategies that you can use to help get your diagnostic method patent over the line in the United States.
-
Trade Mark Update – July 2017
Innofy’s monthly review of Trade Mark Office decisions handed down in July 2017.
-
Australian Full Federal Court Denies Pharmaceutical Patent Term Extension
The Australian Full Federal Court confirmed that “Swiss type” claims do not meet the requirements for pharmaceutical patent term extension allowable under Australian patent law.
-
Diagnostics Inventions in the US: The Situation Worsens…
On 4 August 2017, the United States District Court handed down another…
-
The European Unitary Patent Is Coming…
And why you should take notice
The European Patent Office will soon offer a “one-stop-shop” for your European patent rights. Find out what you need to know about how the European Unitary Patent will work, and how it will present a cheaper way to obtain patent rights across Europe.
-
Five lessons regarding patents vs trade secrets from Game of Thrones “Wildfire”
For those of you that have somehow not been caught up in…
-
The Australian TGA wants to hear from stakeholders
The Australian Therapeutic Goods Administration (TGA) is reaching out! Please take 10-15…
-
Opportunity – FDA encouraging manufacture and distribution of new generic drugs
The U.S. Food and Drug Administration (FDA) are desperately seeking to increase competition for prescription drugs. A recent blog post by the FDA Commissioner has outlined their strategy for reducing the barriers to generic drug approval.
Author archive for Andrew Clarke
Innofy Intellectual Property > Articles by: Andrew Clarke